Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMUEL A FRANK

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1780646349
CMS profile
262743
Location
BOSTON, MA

General Payments · PY2018–2024

$26,648.88

  • Reported across 44 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,019.43

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $4,505.00 3
Food and Beverage $371.94 11
Travel and Lodging $142.49 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
F. Hoffmann-La Roche AG $4,641.12 5
Alnylam Pharmaceuticals Inc. $266.60 6
Teva Pharmaceuticals USA, Inc. $53.89 2
ABBVIE INC. $34.40 1
Neurocrine BioSciences, Inc. $23.42 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $221.45 2
PY2019 $4,461.02 4
PY2020 $3,977.67 6
PY2021 $7,344.61 5
PY2022 $19.38 1
PY2023 $5,605.32 11
PY2024 $5,019.43 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $34.40 04/16/2024 Food and Beverage Undisputed 01/23/2026 1103749717 CMS
Alnylam Pharmaceuticals Inc. $31.24 09/09/2024 Food and Beverage Undisputed 01/23/2026 1125832363 CMS
Alnylam Pharmaceuticals Inc. $142.49 09/10/2024 Travel and Lodging Undisputed 01/23/2026 1125832359 CMS
Alnylam Pharmaceuticals Inc. $26.66 09/10/2024 Food and Beverage Undisputed 01/23/2026 1125832361 CMS
Alnylam Pharmaceuticals Inc. $16.55 09/10/2024 Food and Beverage Undisputed 01/23/2026 1125832529 CMS
Alnylam Pharmaceuticals Inc. $33.11 09/10/2024 Food and Beverage Undisputed 01/23/2026 1125832531 CMS
Alnylam Pharmaceuticals Inc. $16.55 09/10/2024 Food and Beverage Undisputed 01/23/2026 1125832533 CMS
F. Hoffmann-La Roche AG $560.00 05/03/2024 Consulting Fee Undisputed 01/23/2026 1133105716 CMS
F. Hoffmann-La Roche AG $35.10 09/11/2024 Food and Beverage Undisputed 01/23/2026 1133105720 CMS
F. Hoffmann-La Roche AG $840.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1133105724 CMS
F. Hoffmann-La Roche AG $101.02 11/06/2024 Food and Beverage Undisputed 01/23/2026 1133105728 CMS
F. Hoffmann-La Roche AG $3,105.00 11/06/2024 Consulting Fee Undisputed 01/23/2026 1133105732 CMS
Neurocrine Biosciences, Inc. $23.42 04/18/2024 Food and Beverage Undisputed 01/23/2026 1150845115 CMS
Teva Pharmaceuticals USA, Inc. $28.00 02/07/2024 Food and Beverage Undisputed 01/23/2026 1151506386 CMS
Teva Pharmaceuticals USA, Inc. $25.89 11/09/2024 Food and Beverage Undisputed 01/23/2026 1151506504 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.